Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Recipharm
Stockholm, Stockholm, Swedenrecipharm.com ↗
- Ownership
- Private
- Employees
- ~5000
- Development stage
- Commercial
01
Overview
Recipharm does not have its own clinical pipeline but provides end-to-end development and manufacturing services to pharmaceutical and biotech companies globally. It has supported hundreds of products through all phases up to commercial launch. Its biologics/ATMP capabilities were significantly expanded through the acquisition of Arranta Bio, GenIbet and Vibalogics in April 2022. The company’s recent partnership with ProductLife Group aims to accelerate client timelines from early development through market approval.
- Modalities
- Small moleculesBiologics (including mRNA, plasmid DNA, viral vectors)Advanced Therapy Medicinal Products (ATMPs)Microbiome live biotherapeuticsInhaled and nasal drug-device combinations
- Industry
- Contract Manufacturing Organization
02
Partnerships
ProductLife GroupMedspray (via Resyca BV joint venture)
Beyond the preview
Go deeper on Recipharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Recipharm.